A carregar...

ASIC1a Inhibitor mambalgin-2 Suppresses the Growth of Leukemia Cells by Cell Cycle Arrest

Although tyrosine kinase inhibitors have brought significant success in the treatment of chronic myelogenous leukemia, the search for novel molecular targets for the treatment of this disease remains relevant. Earlier, expression of acid-sensing ion channels, ASIC1a, was demonstrated in the chronic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Naturae
Main Authors: Bychkov, M. L., Shulepko, M. A., Vasileva, V. Y., Sudarikova, A. V., Kirpichnikov, M. P., Lyukmanova, E. N.
Formato: Artigo
Idioma:Inglês
Publicado em: A.I. Gordeyev 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7385094/
https://ncbi.nlm.nih.gov/pubmed/32742733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.32607/actanaturae.10949
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!